Evogene Ltd
NASDAQ:EVGN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Evogene Ltd
NASDAQ:EVGN
|
IL |
|
P
|
POET Technologies Inc
XBER:RI4
|
CA |
|
Piovan SpA
MIL:PVN
|
IT |
|
Japan Engine Corp
TSE:6016
|
JP |
|
P
|
Paion AG
XHAM:PA8
|
DE |
|
1nkemia IUCT Group SA
MAD:IKM
|
ES |
|
M
|
MTI Investment SE
STO:MTI
|
SE |
|
K
|
Khoon Group Ltd
HKEX:924
|
SG |
|
Corby Spirit and Wine Ltd
TSX:CSW.A
|
CA |
|
Shanghai Putailai New Energy Technology Co Ltd
SSE:603659
|
CN |
|
G
|
Gav-Yam Lands Corp Ltd
TASE:GVYM
|
IL |
|
Versarien PLC
LSE:VRS
|
UK |
|
M
|
Mediplantex National Pharmaceutical JSC
VN:MED
|
VN |
|
Scanfil Oyj
LSE:0Q59
|
FI |
|
Xiamen C&D Inc
SSE:600153
|
CN |
|
B
|
Berry Global Group Inc
SWB:BP0
|
US |
|
C
|
CI Group PCL
SET:CIG
|
TH |
|
Heron Resources Ltd
ASX:HRR
|
AU |
Evogene Ltd
Evogene Ltd. engages in the development and commercialization of a computer-biological platform for improving the development processes of products in the field of life sciences. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.
Evogene Ltd. engages in the development and commercialization of a computer-biological platform for improving the development processes of products in the field of life sciences. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.
This earnings call has not been analyzed yet.
If you’d like us to analyze this earnings call, click the "Request Earnings Call Analysis" button below.
